Seeking Alpha

CYTR
  CytRx Corporation - NASDAQ

8/23/2014, 3:29 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CYTR vs. ETF Alternatives
Company Description
CytRx Corp is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes three clinical-stage drug candidates in various stages of development: Aldoxorubicin, Tamibarotene, and Bafetinib.
Sector: Healthcare
Industry: Biotechnology
Country: United States